We provide evidence that the mechanism underlying tumor-growth defects conferred by ATF6 disruption involves attenuation of Wnt and Myc signaling, reduced cell-cycle progression and stemness, and increased differentiation. The gene discussed is MYC; the disease is neoplasm.